Strides Pharma Science Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 609.71 | 656.88 | 536.24 |
| Operating Expense | 531.34 | 472.43 | 459.93 |
| Net Profit | 16.35 | 121.90 | 32.04 |
| Net Profit Margin | 2.68% | 18.56% | 5.97% |
| Earning Per Share | 1.77 | 13.22 | 3.48 |
| EBIDTA | 73.83 | 194.33 | 71.59 |
| Effective Tax Rate | 7.18% | 12.35% | -14.90% |
Particulars
Mar 2026
Revenue609.71
Operating Expense531.34
Net Profit16.35
Net Profit Margin2.68
Earning Per Share1.77
EBIDTA73.83
Effective Tax Rate7.18
